Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...
Shares of Merck & Co. Inc. MRK slid 1.81% to $88.05 Thursday, on what proved to be an all-around mixed trading session for ...
Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.
The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
BofA lowered the firm’s price target on Merck (MRK) to $112 from $118 and keeps a Buy rating on the shares. Q4 results were “decent,” but 2025 ...
- LabConnect anuncia la formación de un Consejo Asesor Estratégico y el nombramiento de sus miembros inaugurales Personalised advertising and content, advertising and content measurement, audience ...
LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its ...
La farmacéutica Merck anunció el jueves que tiene previsto interrumpir anticipadamente un estudio de fase avanzada de su fármaco contra la hipertensión arterial pulmonar (HAP) ...
Los demócratas del Senado recuerdan al elegido por Trump para secretario de Salud su insistente postura crítica contra la ...
Su prima, Caroline Kennedy, lo tacha de “depredador” y dice que se llegó a deleitar con una “escena perversa de desesperación ...
El diseñador de chips cede un 1,44% tras haberse hundido un 17% en la sesión del lunes. Más información: La amenaza china de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback